Literature DB >> 32311100

Cysteamine prevents asthma development and reduces airway hyperresponsiveness in experimental asthma.

Paige E Bolcas1,2, Eric B Brandt1, Brandy P Ruff1, Mehak Kalra1, Gurjit K Khurana Hershey1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32311100     DOI： 10.1111/all.14332

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  2 in total

1.  Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

Authors:  Tonino Alonzi; Alessandra Aiello; Linda Petrone; Saeid Najafi Fard; Manuela D'Eletto; Laura Falasca; Roberta Nardacci; Federica Rossin; Giovanni Delogu; Concetta Castilletti; Maria Rosaria Capobianchi; Giuseppe Ippolito; Mauro Piacentini; Delia Goletti
Journal:  Cells       Date:  2021-12-24       Impact factor: 6.600

2.  Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19.

Authors:  Kritika Khanna; Wilfred W Raymond; Jing Jin; Annabelle R Charbit; Irina Gitlin; Monica Tang; Adam D Werts; Edward G Barrett; Jason M Cox; Sharla M Birch; Rachel Martinelli; Hannah S Sperber; Sergej Franz; Thomas Duff; Markus Hoffmann; Anne Marie Healy; Stefan Oscarson; Stefan Pöhlmann; Satish K Pillai; Graham Simmons; John V Fahy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-06-28       Impact factor: 6.011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.